We are live on ! Find out more
CBST

CUBIST PHARMACEUTICALS INC
CBST

Delisted

CBST was delisted on the 21st of January, 2015.

276 hedge funds and large institutions have $7.7B invested in CUBIST PHARMACEUTICALS INC in 2014 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 105 increasing their positions, 107 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more capital invested

Capital invested by funds: $7.35B → $7.7B (+$358M)

3% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 35

0% more funds holding

Funds holding: 276276 (0)

0% more funds holding in top 10

Funds holding in top 10: 88 (0)

2% less repeat investments, than reductions

Existing positions increased: 105 | Existing positions reduced: 107

38% less call options, than puts

Call options by funds: $17.2M | Put options by funds: $27.8M

Holders
276
Holders Change
Holders Change %
0%
% of All Funds
7.97%
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.23%
New
36
Increased
105
Reduced
107
Closed
35
Calls
$17.2M
Puts
$27.8M
Net Calls
-$10.6M
Net Calls Change
-$140M
Name Holding Trade Value Shares
Change
Change in
Stake
Viking Global Investors
276
Viking Global Investors
Connecticut
-$51.1M -741,700 Closed
DFO
277
Duquesne Family Office
New York
-$28.4M -413,000 Closed
DM
278
Deerfield Management
New York
-$26.6M -386,282 Closed
JG
279
Jefferies Group
New York
-$9.62M -139,655 Closed
HT
280
HAP Trading
New York
-$9.24M -134,188 Closed
GTC
281
Ghost Tree Capital
New York
-$3.44M -50,000 Closed
OAM
282
Oxford Asset Management
United Kingdom
-$3.3M -47,868 Closed
ARTA
283
A.R.T. Advisors
New York
-$3.17M -46,090 Closed
State of Tennessee, Department of Treasury
284
State of Tennessee, Department of Treasury
Tennessee
-$2.07M -30,000 Closed
D.E. Shaw & Co
285
D.E. Shaw & Co
New York
-$1.43M -20,801 Closed
IAM
286
Impax Asset Management
New Hampshire
-$1.4M -20,320 Closed
GCP
287
GSA Capital Partners
United Kingdom
-$969K -14,074 Closed
QIM
288
Quantitative Investment Management
Virginia
-$606K -8,800 Closed
HCA
289
Harbour Capital Advisors
Virginia
-$533K -7,745 Closed
KIA
290
King Investment Advisors
Texas
-$519K -7,535 Closed
CB
291
Commerce Bank
Missouri
-$431K -6,266 Closed
MNBTD
292
Moody National Bank Trust Division
Texas
-$344K -5,000 Closed
CA
293
Cetera Advisors
Colorado
-$336K -4,837 Closed
LOM
294
Loeb Offshore Management
New York
-$322K -4,673 Closed
SEC
295
Seven Eight Capital
New York
-$269K -3,900 Closed
Natixis Advisors
296
Natixis Advisors
Massachusetts
-$261K -3,788 Closed
Truist Financial
297
Truist Financial
North Carolina
-$259K -3,762 Closed
Tudor Investment Corp
298
Tudor Investment Corp
Connecticut
-$231K -3,348 Closed
CCM
299
Coldstream Capital Management
Washington
-$226K -3,280 Closed
GCA
300
Greenwood Capital Associates
South Carolina
-$222K -3,224 Closed

CBST Hedge Fund Activity: Q1 2014 in Review

276 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in CUBIST PHARMACEUTICALS INC (CBST) for Q1 2014, worth a combined $7.7B — up 4.9% from $7.35B a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new CBST positions and 35 closed out — a net gain of 1 holder — while 105 added to existing stakes and 107 trimmed.

The largest buyer was BNP Paribas Financial Markets, adding an estimated $636M. The largest seller was Canada Pension Plan Investment Board, cutting an estimated $66M.

  • 276 institutional investors held CUBIST PHARMACEUTICALS INC (CBST) as of Q1 2014, unchanged from Q4 2013.
  • Funds reported $7.7B of CUBIST PHARMACEUTICALS INC stock for Q1 2014, up 4.9% quarter-over-quarter.
  • 36 funds opened new CUBIST PHARMACEUTICALS INC positions in Q1 2014 and 35 closed out, a net change of +1 holder.
  • The largest CUBIST PHARMACEUTICALS INC buyer in Q1 2014 was BNP Paribas Financial Markets, an estimated $636M added.
  • The largest CUBIST PHARMACEUTICALS INC seller in Q1 2014 was Canada Pension Plan Investment Board, an estimated $66M sold.

Based on aggregated 13F filings for Q1 2014.